Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis

BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common functional gastroenterological diseases, affecting 11.2 % of people worldwide. Previous studies have shown that probiotic treatment may benefit IBS patients. However, the effect of probiotics and the appropriate type, dose, and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Li, Lixiang, Guo, Chuanguo, Mu, Dan, Feng, Bingcheng, Zuo, Xiuli, Li, Yanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907258/
https://www.ncbi.nlm.nih.gov/pubmed/27296254
http://dx.doi.org/10.1186/s12876-016-0470-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907258/
https://www.ncbi.nlm.nih.gov/pubmed/27296254
http://dx.doi.org/10.1186/s12876-016-0470-z

Ejemplares similares